Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion
Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest…
News February 3Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest…
News February 3The French Agency for the Safety of Medicines and Health Products selected the companies that will supply France's…
News January 25A consultation on cannabis legalization in France that launched on Jan. 13 has already gathered 200,354 responses, Marijuana…
News January 25The Czech market for medical cannabis flower quadrupled last year compared to 2019, according to data published by…
News January 21Jürgen Bickel, managing director of Germany-based Storz & Bickel, offers business takeaways from 20 years of making cannabis…
News January 19United Kingdom-based GW Pharmaceuticals expects to report annual sales of roughly $526 million for the year ended Dec.…
News January 13As public health-insurance payouts for medical cannabis in Germany stagnate, entrepreneurs are focusing instead on the private health-care…
News January 12Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the…
News January 7The Polish medical cannabis market is growing rapidly, with imports through August 2020 more than doubling compared to…
News January 5Here’s a look back at the year that was through the lens of MJBizDaily‘s most-read marijuana business stories…
News December 28